Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001953204 | SCV002217692 | benign | Kabuki syndrome | 2023-11-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004694031 | SCV005191795 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004542193 | SCV004791592 | uncertain significance | KMT2D-related disorder | 2024-02-07 | no assertion criteria provided | clinical testing | The KMT2D c.15077C>T variant is predicted to result in the amino acid substitution p.Pro5026Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0040% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |